We sat down with one of the most forward-thinking leaders in modern biotech!Dr. Dan Wee is the Chief Execution Officer (CEO) at Enveda Biosciences Enveda is challenging the traditional pharma model. Instead of operating several steps removed from real patients, Dan and the team are building medicines grounded in what people actually feel, experience and need.Since Enveda’s founding at the height of the pandemic, Dan has helped guide the company through the turbulence of biotech cycles while staying focused on one mission: developing the best medicines, as fast and as safely as possible.Chapters:00:00 Intro01:05 The energy of founders + VCs01:45 What Enveda actually does02:41 Mapping life’s chemistry03:38 The first year building Enveda04:50 Founding biotech during the pandemic05:27 Staying focused through turbulent markets06:20 The gap between pharma and real patients07:14 How Enveda bridges that gap08:20 Why chronic diseases need new medicines09:12 Modernity, antibiotics, and unexpected consequences10:03 Building for patients who live with conditions dailyHuge thanks to Dan for making the time!#foundersandbuilders #danwee #slush2025